We realize, therefore, while the combined detection of SHOX2, RASSF1A, and PTGER4 gene in plasma achieved a high detection specificity in lung cancer diagnosis, the exact number of patients in other different tumors may be insufficient; to confirm the results, more clinical data would be needed in further studies. Here, SHOX2 is linked to lung cancer.